CytRx (CYTR) – Corporate News
-
CytRx (CYTR) Highlights Strategic Purchase of Arimoclomol by KemPharm
-
CytRx (CYTR) Highlights Orphazyme's Completion of Rolling Submission of its NDA with the U.S. FDA for Arimoclomol in Niemann-Pick Disease Type-C
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CYTR Stock Lookup